BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY Investigational...
BD (Becton, Dickinson and Company) (NYSE: BDX) a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and Conformité...
At BD, our mission of Advancing the World of Health™ means more than developing innovative medical technologies, it’s about making sure those innovations are accessible to the people who need...
September marks Gynecologic Cancer Awareness Month, a time to elevate conversations about the cancers that affect millions of women worldwide. Among them, cervical cancer stands out for a powerful...
Discover the new BD. We create medical technology, devices and laboratory equipment for scores of different needs across the healthcare continuum. But we serve all of them with one single and relentless human purpose: advancing the world of health. This is how we make a difference in human health across generations. This is our work and this is our passion.
The BD Innovation and Engagement Center in Eysins Switzerland offers visiting healthcare professionals a collaborative and immersive environment to grasp the full scope of BD solutions to healthcare challenges across the care continuum.
